"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
To be decided by the editor
This interview will look into talking about different systems used for analyzing gait in animals, in treadmill versus non-treadmill systems.
This interview talks to Andre Kotze about the different services and products available at Azenta.
In this interview, Dr. Ignacio Duran and Alex Filicevas focus on improving dialogue between healthcare professionals and patients, outlining ways in which we can encourage open discussion to improve the overall patient experience.
In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.
In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.
In this interview, Jean Fallacara, Managing Director at inTEST Thermal Solutions, talks to us about the future of cold storage and how inTEST is helping move the industry forward.
In this interview, Dr. Ignacio Durán and Alex Filicevas discuss key challenges and opportunities in the bladder cancer disease landscape and the future of care. This episode focuses on the bladder cancer patient support landscape, including a review of the tools and resources available to the community, as well as key unmet needs to address.
In this interview, Dr. Ignacio Durán and Alex Filicevas, discuss key challenges and opportunities in the bladder cancer disease landscape and the future of care. They focus on the quality of life for patients and delve into the impact bladder cancer has on daily life, both before and after diagnosis and treatment, from the holistic perspective of both patients and HCPs.
In this interview, News-Medical speaks to Zoë Thomson, Co-founder and Chief Innovation Officer of LUCID, about how music and machine learning are changing how we approach mental and neuropsychiatric health.
Analyzing narcotics in crime labs is an integral part of efforts to keep the dispersion and use of dangerous substances under control. While there are multiple scientific methods that can be used for narcotics analysis, nuclear magnetic resonance (NMR) is particularly innovative and useful.
In this interview, we talk to Takayuki Baba about ongoing research using artificial intelligence to achieve earlier diagnosis of pancreatic cancer.
In this interview, we speak to Matt Walz, CEO of Trialbee, about the importance of improving patient recruitment and retention within clinical trials.
In this interview, News-Medical speaks to Thanh T. Nguyen, a project manager at Innocore Pharmaceuticals, about the mechanisms behind long-acting injectables.
In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius.
In this interview, we speak to Michelle Egger, CEO, and Co-Founder of BIOMILQ, about their breakthrough mammary biotechnology.
My work is focused on looking at the dynamics of B/T cell populations within lymph nodes from patients that had recovered from COVID-19. My role in this research was developing and implementing microscopy image analysis techniques using methods and instrumentation in part supplied by TissueGnostics.
In this interview, Steffen van Heijningen discusses the differences between individual and social housing
of mice and how housing conditions can impact the research.
To be decided by the editor
In this interview, we speak to Sheetal Parmar, vice president of medical affairs and head of clinical services at Natera, about their cell-free DNA (cfDNA) testing services.